Deeming it a “proactive step” in once again proving that its practices are lawful, the University of Pittsburgh says it’s asked a Washington law firm to review its fetal tissue research practices.
In a statement Thursday, the university confirmed it has retained Hyman Phelps & McNamara — a firm that lists internal investigations among its main areas of practice — to do an independent review of what’s become a hot-button issue among conservative media circles and anti-abortion advocates.
Republican state lawmakers and anti-abortion groups — as well as a leading contender for the GOP nomination for the U.S. Senate — have raised questions and accusations about the university’s fetal tissue research practices. The university has repeatedly denied any wrongdoing.
“Fetal tissue research is subject to robust internal controls at Pitt and highly regulated at the state and federal level,” Pitt’s statement read. “The University routinely conducts reviews to ensure that its research activities — across all areas of research — comply with internal policies as well as all relevant federal and state laws.”
The use of fetal tissue and cells is common among research institutions, and was crucial in the development of vaccines for polio, chickenpox and measles. The American Medical Association says fetal tissue research “has led to the development of a number of important research and medical advances.”
But it’s long been the target of anti-abortion activists who liken it to using aborted babies as guinea pigs for experimentation. The chairman of the U.S. Conference of Catholic Bishops’ Committee on Pro-Life Activities said earlier this year that the research treats “innocent abortion victims as a commodity that can be scavenged for body parts to be used in research.”
Read More
When Pennsylvania’s legislature considered the university’s funding earlier this year, one GOP lawmaker said his “no” vote was because he didn’t want to send taxpayer money to a university that commits “deplorable, grotesque and morally offensive” atrocities in the name of research to aborted babies.
Scientists note that the practice of using fetal tissue and cells for research is strictly regulated across the country — especially in Pennsylvania — and that there are numerous protections in place so that proper consent is obtained and monetary gain is prohibited.
At Pitt, the firm’s review is underway, the university said, and once complete, the firm’s members will “brief University senior leadership of their findings,” the statement read. The Hyman, Phelps & McNamara firm is “well respected for its extensive experience navigating the intersections of health care, research and regulatory law,” Pitt added.
“Pitt has taken this proactive step to ensure that it is positioned to continue leading the way — scientifically, legally and ethically — in practicing and advancing lifesaving research,” the university’s statement continued.
State Rep. Natalie Mihalek, R-Upper St. Clair, a member of Pitt’s Board of Trustees who first announced the university’s move for a third-party review, said “an open and transparent review by an independent third party” is the best path forward for a university facing accusations.
The issue has intersected with politics, and the school has found itself in the resulting crosshairs. The Pennsylvania state House’s health committee honed in on the accusations against Pitt at a hearing in May.
Some anti-abortion advocates — including GOP U.S. Senate candidate Sean Parnell — have gone as far as to allege Pitt is harvesting the kidneys of unborn babies while their hearts were still beating, claims that have been amplified by Fox News and conservative websites.
“As we have repeatedly noted, the University of Pittsburgh does not perform medical procedures and is not part of the tissue collection process,” David Seldin, Pitt’s vice chancellor for news, told Fox News in August. “All of the University’s research is closely supervised to ensure compliance with strict and rigorous federal and state laws and regulations.”
Rep. Dan Frankel, who serves as Pennsylvania Gov. Tom Wolf’s representative on the university’s board, praised the school’s move and said he expects the report to put an end to accusations.
“Faced with a relentless barrage of baseless attacks, the University of Pittsburgh is fighting bad faith lies with openness and honesty,” said Mr. Frankel, Democratic ranking member of the House’s health committee. “I have total confidence that the school will show itself to be what it always has been: a champion for science and research.”
Julian Routh: jrouth@post-gazette.com; Twitter @julianrouth




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.